The effect of intracerebroventricular norepinephrine on dentate gyrus evoked potentials in anaesthetized and awake, behaving rats by Chaulk, Paul Cyril
CENTRE FOR NEWFOUNDLAND STUDIES 
TOTAL OF 10 PAGES ONLY 
MAY BE XEROXED 
(Without Author's Permission) 


1+1 National Ubrary of Canada Bibliotheque nationale du Canada 
Acquisitions and Direction des acquisitions et 
Bibliographic Services Branch des services bibliographiques 
395 Wellington Street 
Ottawa, Ontario 
K1AON4 
395, rue Wellington 
Ottawa (Ontario) 
K1AON4 
THE AUTHOR HAS GRANTED AN 
IRREVOCABLE NON-EXCLUSIVE 
LICENCE ALLOWING THE NATIONAL 
LffiRARY OF CANADA TO 
REPRODUCE, LOAN, DISTRmUTE OR 
SELL COPIES OF HIS/HER THESIS BY 
ANY MEANS AND IN ANY FORM OR 
FORMAT, MAKING THIS THESIS 
AVAILABLE TO INTERESTED 
PERSONS. 
THE AUTHOR RETAINS OWNERSHIP 
OF THE COPYRIGHT IN HIS/HER 
THESIS. NEITHER THE THESIS NOR 
SUBSTANTIAL EXTRACTS FROM IT 
MAY BE PRINTED OR OTHERWISE 
REPRODUCED WITHOUT HIS/HER 
PERMISSION. 
ISBN 0-315-96036-1 
Canada 
Your file Votre ref(Nence 
Our file Noire ret8rence 
L'AUTEUR A ACCORDE UNE LICENCE 
IRREVOCABLE ET NON EXCLUSIVE 
PERMETT ANT A LA BffiLIOTHEQUE 
NATIONALE DU CANADA DE 
REPRODUIRE, PRETER, DISTRmUER 
OU VENDRE DES COPIES DE SA 
THESE DE QUELQUE MANIERE ET 
SOUS QUELQUE FORME QUE CE SOIT 
POUR METTRE DES EXE~LAIRES DE 
CETTE THESE A LA DISPOSITION DES 
PERSONNE INTERESSEES. 
L'AUTEUR CONSERVE LA PROPRIETE 
DU DROIT D'AUTEUR QUI PROTEGE 
SA THESE. NI LA THESE NI DES 
EXTRAITS SUBST ANTIELS DE CELLE-
CI NE DOIVENT ETRE ~RIMES OU 
AUTREMENT REPRODUITS SANS SON 
AUTORISATION. 
THE EFFECT OF INI'RACEREBROVEN'IRICULAR NOREPINEPHRINE 
ON DENTATE GYRUS EVOKED POTENTIALS 
IN AJ:\JAESTHETIZED AND AWAKE I BEHAVING RATS . 
BY 
PAUL CYRIL CHAULK 
A thesis submitted to the School of Graduate 
Studies in part ial fulfilment of the 
requirements for the degree of 
St. John's 
Master of Science 
Department of Psychology 
Memorial University of Newfoundland 
1994 
Newfoundland 
ll 
Abstract: Exogenous application of norepinephrine (NE) or 
stimulation of endogenous NE release has been shown to 
potentiate the perforant path-evoked dentate gyrus population 
spike (popspike). In vitro studies (Lacaille and Harley, 1985) 
suggest beta receptor mediation of the enhancement. In 
contrast, an in vivo study (Winson and Dahl, 1985) implicates 
alpha receptors. The present study utilizes 
intracerebroventricular (icv) administration of NE (1, 10, 50, 
100 ~g)as well as alpha and beta agonists and antagonists in 
urethane-anaesthetized rats in order to examine in vitro-like 
bath application conditions in the intact preparation. The 
effect of icv NE was also assessed in awake, behaving animals. 
In the anaesthetized rat, NE as well as the beta agonist 
isoproterenol reliably potentiated the population spike 
(popspike) amplitude. The alpha agonist phenylephrine 
potentiated the popspike in a majority of experiments. The 
icv-induced enhancement was frequently long-lasting for the 
beta agonist isoproterenol and higher doses of NE (50 ,100 ~g) . 
Both alpha (phentolamine) and beta (metoprolol) antagonists 
blocked the NE induced potentiation in a majority of 
experiments. However, only the alpha antagonism was 
significant. EPSP slope changes were inconsistent. NE (10 ~g) 
produced a potentiation in the awake, behaving rat which was 
virtually indistinguishable from that obtained with the same 
dose in the anaesthetized preparation. These results suggest 
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that the icv methodology is a reliable method of producing 
popspike potentiation by exogenous NE application in vivo. 
Secondly, the results suggest a possible role for alpha as 
well as beta receptors in the NE potentiation effect in the 
dentate gyrus. Finally, the results extend the finding of NE 
induced potentiation to exogenously applied NE in the awake 
animal. 
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General Introduction. 
The hippocampus has been implicated in learning, memory 
formation and attentional processes in the mammalian brain 
(Isaacson and Pribham, 1975, 1986; O'Keefe and Nadel, 1978; 
Olton, 1983; Squire, 1986). Long-term potentiation (LTP) in 
the hippocampus, induced by high frequency stimulation, has 
been the most widely studied model of neuronal plasticity. 
Diffuse, modulatory inputs to the hippocampus have also been 
shown to be important in hippocampal functioning. In this 
regard, norepinephrine (NE) has been shown to produce both 
short and long-term enhancement of the dentate gyrus response 
to stimulation of the major hippocampal input, the perforant 
path, which originates in the entorhinal cortex. This thesis 
is concerned primarily with (1) establishing icv injection as 
a method of inducing potentiation with exogenous NE 
application (2) investigating the pharmacology of this NE 
potentiation in vivo and (3) extending the finding of 
potentiation to exogenous NE to the awake, behaving animal. 
The perforant path, also known as the angular bundle, is 
comprised of a medial-lateral gradient of input (Steward, 
1976). However, given the resolution of large stimulating 
electrodes, they may be thought of as composing two types of 
fibres. Fibres arising in the medial entorhinal cortex which 
are thought to carry visual and auditory sensory modalities 
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synapse in the middle layer of the dendritic tree of the 
dentate gyrus (Cragg, 1961; Krettek and Price, 1977) . Fibres 
arising from the lateral entorhinal cortex carry olfactory and 
subcortical inputs, and synapse in the apical portion (outer-
third layer) of the dendritic tree (Cragg, 1961; Krettek and 
Price, 1977) . These dendrites arise from the granule cells in 
the dentate gyrus, the axons of which project to CA3 of the 
hippocampus. The hilar region between the two blades of the 
dentate gyrus contains a large variety of interneurons ( Caj al, 
1968; Amaral, 1978), most of which are presumably inhibitory 
(Anderson, 1975; Buzsaki and Eidelberg, 1981; Seress and 
Ribak, 1984; Scharfman et al. , 1990; Schwartzkroin et al. 
1990) . 
NE synapses in the hippocampus originate solely from the 
locus coeruleus (LC) via the dorsal noradrenergic bundle (Koda 
and Bloom, 1977) . The predominant excitatory input to the LC 
arises in the medullary nucleus paragigantocellularis (PGI) 
(Ennis and Aston-Jones, 1986, 1987). 
All studies of NE effects on neuronal plasticity in the 
dentate gyrus have involved stimulation of the perforant path 
at a low frequency while recording the evoked response at 
either the dendritic or granule cell layer. Two measures are 
taken as indices of the evoked response. The slope of the 
Excitatory-Post-Synaptic-Potential (EPSP) is taken as an index 
of activation of the dendritic tree; this reflects the 
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combined effect of the number of perforant path fibres 
activated by the stimulation, the amount of neurotransmitter 
released and the sensitivity of postsynaptic receptors (Lorna, 
1971) . The population spike (popspike) amplitude is taken as 
a measure of the number of cells that fire in response to the 
neurotransmitter activation. Using this basic paradigm, 
differences have emerged between effects of bath application 
of NE in vitro in the hippocampal slice and in vivo methods of 
NE application. In vitro, NE has been introduced by bath 
application (i.e. superfusion) (Lacaille and Harley, 1985; 
Stanton and Sarvey, 1985a) . In the intact, anaesthetized 
animal, NE has been introduced by iontophoresis (Neuman and 
Harley, 1983; Winson and Dahl, 1985), via electrical or 
chemical activation of the LC (Dahl and Winson, 1985; Harley 
and Milway, 1986; Harley and Evans, 1988; Washburn and Moises, 
1989; Harley, Milway and Lacaille, 1989; Klukowski, 1993), or 
via electrical activation of the PGI (Harley and Babstock, 
1992) . 
NE Potentiation of Popspike Anplitude. 
A common feature of NE application, regardless of method 
of application, is a potentiation of popspike amplitude, 
recorded at the granule cell layer, that is frequently long-
lasting. 
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There were two initial reports of NE facilitation of 
popspike amplitude in the hippocampal slice. In one, ten 
rranutes of NE (10 ~M) superfusion produced a 31% enhancement 
that was long-lasting in one-quarter of experiments (Lacaille 
and Harley, 1985) . In the other, thirty rranutes of NE 
superfusion produced enhancement that persisted after a 30 
rran. wash with a concentration of 20 ~M needed to produce 
half-maximal potentiation (Stanton and Sarvey, 1985a) . The 
mean maximal increase was approximately 85% greater than 
control. Sirralar results had been reported in the 
anaesthetized animal. Neuman and Harley (1983) initially 
reported that 1-8 rran. iontophoretic application of NE at the 
granule cell layer produced a potentiation of the popspike of 
a magnitude between 20 and 400% that was long-lasting at 39% 
of the sites. Sirralarly, Winson and Dahl (1985) reported long-
lasting enhancement of the popspike amplitude in 3 of 8 
preparations using 5 rran. iontophoresis of NE. However, they 
also reported potentiation to the inactive isomer, d-NE, in 2 
of 5 preparations. 
Since these reports, popspike enhancement has been 
reliably found following activation of the LC to stimulate 
endogenous release of NE. The facilitation was approximately 
40% greater than control and lasted more than 20 rran. in 39% 
of animals following glutamate ejection in the LC (Harley and 
Milway, 1986) . Harley and Evans (1988) replicated this 
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finding. Klukowski (1993) extended this finding to show that 
glutamate activation of the LC produced potentiation in the 
awake animal. Activation of the LC by electrical stimulation 
of the PGI produced a 39% increase in the popspike amplitude 
at a inter-stimulus interval between PGI and perforant path 
stimulation of 30 ms (range 20 - 50 ms) . These effects were 
generally short-lasting (Babstock and Harley, 1992) . Finally, 
electrical stimulation of the LC has produced popspike 
facilitation which may, however, be partly due to activation 
of fibres of passage (Winson and Dahl, 1985; Harley, Milway 
and Lacaille 1989; Washburn and Moises, 1989) . Furthermore, it 
is possible that electrical stimulation causes an 
unphysiological release pattern of NE as well as promoting the 
release of peptides. 
Overall, a clear pattern of NE facilitation of popspike 
amplitude in the dentate gyrus has emerged. The present study 
will introduce a new method of eliciting NE-induced long-
lasting potentiation (NELLP) and extend it to the awake, 
behaving animal . 
Pharmacology of NE Effects In Vitro. 
While popspike enhancement has been consistently shown in 
different preparations, the pharmacology of NE effects on 
popspike amplitude with exogenous application differs markedly 
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between in vitro and in vivo studies . The pharmacology of NE 
effects was initially characterized in slice work. Lacaille 
and Harley (1985) reported that isoproterenol (ISO), a beta 
agonist, produced a larger facilitation of popspike amplitude 
than NE itself. Although the authors concluded that alpha 
agonists failed to mimic the effects of NE, PE, an alpha 
agonist, did facilitate the popspike on 29% of slices. 
However, in other studies, NELLP was demonstrated at a lower 
NE concentration if an alpha antagonist was added to the slice 
bath (e.g. Dahl and Sarvey, 1989) . The facilitation in 
popspike amplitude seen in slices following NE superfusion has 
been prevented by prior bath application of timolol (beta 
antagonist) (Lacaille and Harley, 1985), propranolol (beta 
antagonist) and metoprolol (MET, beta-1 antagonist) (Stanton 
and Sarvey, 1985a) . The alpha antagonist phentolamine has not 
effectively blocked the NE enhancement of popspike amplitude 
(Lacaille and Harley, 1985) . 
Pharmacology of NE Effects In Vivo. 
The only pharmacological investigation of exogenous 
application of NE in vivo provides a complete contrast to the 
results obtained from slices. Winson and Dahl (1985) reported 
the opposite pharmacology following iontophoresis in the 
anaesthetized rat. With application at the cell body layer, 
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the beta agonist ISO decreased the popspike whereas the beta 
antagonist sotalol increased it. Conversely, the alpha agonist 
phenylephrine (PE) increased the popspike and the alpha 
antagonist prazosin decreased it. It is important to note that 
these effects occurred only during iontophoresis of the drug; 
long-term effects were not reported. Furthermore, the effects 
only occurred in a minority of preparations, so it is unclear 
whether the drugs are having an effect or there are 
methodological problems. Finally, the effect of ISO (beta 
agonist) could not be blocked by prior iontophoresis of the 
beta-antagonist sotalol. No attempt was made to block the 
effects of NE in the other iontophoretic studies (Neuman and 
Harley, 1983; Winson and Dahl, 1985). 
Despite the lack of further in vivo pharmacological 
studies, a number of in vivo studies have examined the ability 
of a single antagonist (generally beta) to prevent the 
increase in popspike amplitude initiated by LC or PGI 
activation. NE effects on popspike amplitude following LC 
activation by glutamate ejection or PGI stimulation were 
blocked by a beta antagonist and this result was obtained with 
both peripheral injection of propranolol (Harley and Milway, 
1986; Babstock and Harley, 1992) and local cannula application 
of propranolol or timolol in the dentate gyrus itself (Harley 
and Evans, 1988). A closer examination reveals that the result 
was usually an attenuation of the NE effect rather than a 
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complete blockage. Therefore, there may be room to demonstrate 
an effect of alpha antagonists on the NE potentiation. 
NE potentiation following electrical stimulation of the 
LC was not attenuated by propranolol although glutamate 
activation effects were blocked (Harley, Milway and Lacaille, 
1989) . This was likely due to spreading activation of 
surrounding axons by the stimulation electrode since Washbum 
and Moises (1989) used half-maximal stimulation intensities 
and reported that the LC facilitation was blocked by 
peripheral injection of propranolol. While it appears clear 
that beta receptors are involved in NE effects on the popspike 
in vivo, the possible influence of alpha receptors has not 
been resolved. 
NE Effects in Other Brain Areas. 
Pha:rmacological evidence (Winson and Dahl, 1985) has 
already been presented for the involvement of alpha receptors 
in NE potentiation in the hippocampus. A second line of 
evidence that suggests a role for alpha receptors in NE 
potentiation originates from pha:rmacological studies of NE 
effects elsewhere in the brain. 
Most in vivo reports of the pha:rmacology of NE effects 
outside the hippocampus consist of alpha -1 mediated 
enhancement of excitation and beta mediated enhancement of 
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inhibition. Waterhouse et al. (1981) reported that NE 
facilitated the responses of somatosensory cortical neurons to 
natural forepaw stimulation and iontophoresis of ACh 
(acetylcholine) 1 in vivo. This effect was mimicked by the 
alpha agonist/ PE 1 but not the beta agonist/ IS0 1 and blocked 
by phentolamine (PHENT 1 alpha-1 antagonist) but not sotalol 
(beta antagonist) suggesting the effect was mediated by alpha 
receptors. Similarly/ in vivo/ Mouradian et al. (1991) applied 
drugs by iontophoresis into the rat somatosensory cortex and 
evaluated NE enhancement of single unit responses to ACh and 
GLU. The facilitatory action of NE was mimicked by PE and 
phorbol ester activation of protein kinase C (PKC) and blocked 
by PHENT. There was no evidence for a beta component since 
sotalol and propranolol (beta antagonists) failed to block the 
NE effect and a cyclic AMP analogue failed to mimic the NE 
effect. In the dorsal ~ (lateral geniculate nucleus) 1 
recorded in vivo/ both iontophoretically applied NE and LC 
stimulation enhanced synaptic excitation/ an effect blocked by 
an alpha antagonist (WB-4101) (Rogawski and Aghajanian/ 1980) . 
Waterhouse et al. (1982) performed in vivo recording from 
somatosensory cortical neurons in response to iontophoretic 
application of GABA (gamma-amino-butyric acid/ an inhibitory 
neurotransmitter) . NE and IS0 1 but not PE increased the GABA 
induced inhibition of neuronal firing rates whereas sotalol 
blocked the increased inhibition. 
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An in vitro report suggested a pharmacological profile 
in contrast to the above in vivo studies. Dodt et al. (1991) 
applied NE and various agonists to the perfusion media of 
cortical slices while recording intracellularly from 
somatosensory neurons. NE decreased the EPSP, which was 
mimicked by PE, and increased neuronal excitability to current 
injection, which was mimicked by the beta agonist 
isoprenaline. Finally, a contradictory in vivo report by 
Lehrnenkuler and colleagues (1991) suggested that pressure 
ejection of NE reduced the negative CFP (cortical field 
potential) induced by NMDA. This appeared to be alpha mediated 
since it was mimicked by PE but not ISO. 
To summarize, it appears that NE enhancement of 
excitation is mediated by alpha receptors whereas NE 
enhancement of inhibition is mediated by beta receptors in the 
cortex and lGN, in vivo. An in vitro study suggested the 
opposite picture of alpha mediation of inhibition and beta 
mediation of excitation. The suggestion of alpha mediated 
excitation in other brain structures highlights the importance 
of evaluating possible alpha mediation of the NE effect in the 
hippocampus. As well, the difference between in vivo and in 
vitro studies in the hippocampus and other brain structures 
points to the need to evaluate the pharmacology of the NE 
effect in vivo. Even if the hippocampus does prove to be 
different from other structures, the pharmacology will still 
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need to be established in vivo. 
Alpha and Beta Receptor Distribution. 
Taken together, the Winson and Dahl (1985) in vivo 
phannacological study and evidence of NE effects on excitatory 
input elsewhere in the brain strongly suggest a possible role 
for alpha receptors in the hippocarrpus in enhancing the 
glutamatergic perforant path input. Furthermore, 
autoradiography studies show that both alpha and beta 
receptors are present in the hippocarrpus. 
Rainbow et al. (1984) demonstrated that there were high 
levels of beta receptors in the hippocarrpus, 75-85% of which 
were beta-1. Young and Kuhar (1980) reported that alpha-1 
receptor levels were low to moderate in the hippocarrpus 
although the caudal dentate gyrus and molecular layer of the 
dentate gyrus showed relatively higher levels. Finally, 
Rainbow and Biegon (1983) described low levels of alpha-1 
receptors in the hippocarrpus except for the dentate gyrus 
where receptor density was closer to moderate levels. Actual 
densities reported were higher for alpha-1 receptors (150 +/-
14 fmol/mg protein; Rainbow and Biegon, 1983) than for beta 
receptors (41. 6 +I- 4 to 53.4 +/ -5 fmol/mg protein; Rainbow et 
al. , 1984) . 
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In Vivo vs. In Vitro Comparison. 
The in vivo preparation contains much richer innervation 
than the in vitro preparation, as well as having tonically 
active inputs. While the non-specific beta antagonist 
propranolol has been shown to block or attenuate potentiation 
effects of endogenous NE release in vivo, no attempt has been 
made to reconcile reported differences in pharmacology between 
exogenous NE application in vitro and in vivo. In this study, 
we approach the question by using an in vivo preparation in 
combination with "bath-like" icv administration. Problems with 
this approach include effects on other structures but it 
avoids problems with disconnected circuitry in the slice as 
well as any effects caused by local iontophoresis of drugs. 
EPSP Slope. 
In addition to the primary purpose of investigating NE 
effects on the hippocampal popspike, this study will also 
examine other less critical issues such as NE effects on EPSP 
slope and latency measures. 
While enhancement of the popspike has been ubiquitously 
reported in both in vitro and in vivo preparations, effects on 
the EPSP slope in the slice are unlike those reported in 
anaesthetized rats. In vitro studies have all reported NE 
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enhancement of EPSP slope (Lacaille and Harley, 1985; Burgard, 
Decker and Sarvey, 1989; Stanton and Sarvey, 1989). In vivo 
studies have reported predominantly increases (Harley and 
Milway, 1986; Harley and Evans, 1988), predominantly decreases 
(Harley, Milway and Lacaille, 1989) or an absence of any 
consistent effects (Neuman and Harley, 1983; Babstock and 
Harley, 1992; Washburn and Moises, 1989). Two in vivo studies 
have reported differential effects depending upon the area of 
the dentate gyrus involved. In one, the field EPSP was 
unchanged at the granule cell layer but decreased at the 
dendritic tree (Dahl and Winson, 1985). In the other, Winson 
and Dahl (1985) report different effects following NE 
iontophoresis depending upon the micropipette positioning. 
When NE was applied in the middle third of the dendrites, the 
EPSP was reduced. When NE was applied at the granule cell 
layer, changes in the EPSP were inconsistent. 
Overall, the consistent increases in EPSP slope seen in 
slices have not been replicated in anaesthetized rats. A 
possible explanation for this difference lies in the 
electrode positioning since most in vivo studies have recorded 
the EPSP at the granule cell layer whereas in vitro studies 
recorded in the dendritic layer. As demonstrated in Winson and 
Dahl (1985), the positive EPSP recorded at the granule cell 
layer may not reflect changes in the negative EPSP at the 
dendritic layer. 
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Popspike Onset Latency. 
Popspike onset latency may be useful as an indicator of 
possible temperature modulation of the popspike. This may be 
important in the present study since temperature changes may 
be an alternate explanation of some of the effects of icv NE 
application. However, this measure has been infrequently 
reported. Lacaille and Harley (1985) reported a consistent 
decrease of 6% in the popspike onset latency following bath 
superfusion of NE in vitro. As with other measures, latency 
changes in vitro have not been consistently replicated in 
vivo. Two studies have found the absence of any consistent 
changes in onset latency following LC activation (Harley and 
Milway, 1986; Harley and Evans, 1988). Babstock and Harley 
(1992) gave the only in vivo report of decreased popspike 
onset latency following stimulation of the PGI. 
Medial vs. Lateral Perforant Path Effects. 
An important in vitro study suggests that NE 
differentially affects the medial and lateral perforant path 
inputs to the dentate gyrus (Dahl and Sarvey, 1989). A 30 min. 
perfusion with NE and PHENT (an alpha antagonist) produced a 
103% and 43% potentiation of the popspike amplitude and EPSP 
slope, respectively, to medial perforant path stimulation. At 
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the same time, the popspike and EPSP elicited by lateral 
perforant path stimulation were depressed by 22% and 17%, 
respectively. Taken together with the reports of differing 
effects on the EPSP at different layers, the response to NE 
appears to be specific to type of input. 
Rationale for Present Experiment. 
The present study is concerned with demonstrating the 
feasibility of using intracerebroventricular ( icv) NE and drug 
administration which was conceived of as an in vivo 'bath 
superfusion' of the hippocampus that is more similar to slice 
methods than iontophoresis. Secondly, the present study 
undertakes to investigate reported differences in the 
pharmacology of the NE potentiation that exists between in 
vivo and in vitro preparations. In this regard, the icv 
method avoids difficulties associated with precise location of 
NE infusion in the dentate gyrus, as well as iontophoretic 
charge effects, while allowing the investigation of the 
effects of various agonists and antagonists in the whole 
animal. Finally, the present study will attempt to demonstrate 
the existence of exogenous NE potentiation of the dentate 
gyrus population spike in the awake, behaving animal. 
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MATERIALS AND METHODS 
EXPERIMENT 1 - ACUTE STUDIES 
Fifty-two female Sprague-Dawley rats (obtained from 
Charles River Canada, Montreal) under urethane anaesthesia 
(1.5 g/kg) were maintained at normal rectal body temperature 
by means of a hot water blanket running underneath the animal . 
A metal guide cannula was implanted approximately 2 0 0 11m above 
the left lateral ventricle at stereotaxic coordinates 0.8 mm 
posterior to bregma, 1. 5 mm lateral to midline and 3 .1 mm 
ventral from dura. The cannula was held in position by dental 
cement attached to a skull screw. A bipolar metal electrode 
was directed at the perforant path using coordinates 7.1 mm 
posterior to bregma, 4 . 2 mm lateral to midline and 3 . 5 mm 
ventral from dura. Activation of the medial perforant path was 
confirmed by latency to popspike measures. (It was assumed 
that the popspike reflected medial perforant path activation 
whereas the EPSP was a mixture of medial and lateral perforant 
path activation) . A tungsten electrode or glass pipette filled 
with pontamine sky blue (30-60 Jlm tip diameter) served as the 
recording electrode. It was directed at coordinates 3.5 mm 
posterior to bregma and 2 . 0 mm lateral to midline and 
positioned vertically in the dentate gyrus cell body layer 
according to electrophysiological criteria. 
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The perforant path was stimulated at .1 Hz with square 
wave pulses and the dentate gyrus evoked potential was 
digitized at 10 kHz and monitored on-line using software 
developed in this laboratory using Asyst. The sampling 
frequency was 1 point per 10 f.lS or 1 point per 20 f.lS. 
Parameter extraction was performed for 1) EPSP slope (sampled 
over a 300 microsecond interval beginning 750 microseconds 
before the first positive peak) 2) popspike amplitude 
(vertical change from first positive peak to first valley) and 
3) popspike onset latency (from stimulus artifact to first 
positive peak) . For all experiments except the highest dose of 
NE and each agonist the stimulation was decreased until the 
popspike was approximately 50-60% of maximal amplitude before 
any injections were performed. Data were combined into one 
minute means and a 95% confidence interval (t-test) was 
generated for the ten minute control period prior to icv 
injections. Evoked potentials were collected for 30 minutes 
post-injection. Effects were considered significant if at 
least three one minute means exceeded the confidence limits. 
Effects were considered long-lasting if they exceeded 20 min. 
in duration. 
An injection cannula connected via plastic tubing to a 5 
f.ll syringe was placed inside the guide cannula and projected 
approximately 0. 6 - 1. 0 rrm beyond the guide cannula tip into 
the lateral ventricle. All icv injections consisted of a 2 f.ll 
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volume applied by unilateral freehand injection over 1-2 
minutes. Drugs used in this experiment included the racemic 
mixture of norepinephrine (1, 10, 50, 100 ~g), isoproterenol 
(10, 30, 60 g), phenylephrine (10, 50, 100, 300, 500 ~g), 
metoprolol (10 ~g) and phentolamine (30 ~g) . All drugs were 
dissolved in 0.9% saline except phentolamine which was 
dissolved in distilled water with the application of gentle 
heat. 
During agonist experiments, one to four different drug 
dosages were applied per animal with a minimum 45 minute 
interval between infusions. No subsequent injection was given 
until the popspike amplitude had returned to baseline. Each 
drug dosage was given as the first injection for at least two 
different animals and the order of injections was varied. On 
two separate occasions, the same drug dosage was given twice 
in the same animal . Over the series of experiments, the 
highest dose of each drug was used initially and progressively 
lower doses were used until an ineffective dose was reached. 
During antagonist experiments, metoprolol was injected 3 0 
minutes prior to application of isoproterenol (30 ~g) or 
norepinephrine (10 ~g). Phentolamine was injected 30 min prior 
to application of phenylephrine (50 ~g) and 15 minutes prior 
to application of norepinephrine (10 ~g) . These time intervals 
were chosen in order to avoid short lasting effects which 
sometimes occurred following injection of either antagonist 
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alone. No other injections were performed during antagonist 
experiments. 
Immediately prior to sacrifice, animals received a 2 ~1 
injection of pontamine sky blue which was used during later 
histology to verify injection cannula placement inside the 
lateral ventricle. Dye perfusion of the lateral ventricle was 
verified by visual inspection immediately after brain removal. 
Cannula placement and electrode tracts were visualized using 
differentiated cresyl violet staining. In cases where 
electrode tracts were not visible, electrophysiological 
criteria were the only criteria of electrode placement. 
EXPERIMENT 2 - CHRONIC STUDIES 
Five female Sprague-Dawley rats (342 to 514 g; retired 
breeders, except for one) were anaesthetized with Avertin, 
supplemented as needed. (All rats were obtained from Charles 
River Canada, Montreal.) A guide cannula, tungsten recording 
electrode and bipolar stimulating electrode were implanted 
according to the coordinates listed in Experiment 1 . A 
stainless steel ground screw electrode was positioned on the 
opposite skull surface and three other screws were placed 
around the electrodes. The assemblage was secured with dental 
cement and the wound was closed without suture. The dental 
cement was allowed to cover the edge of the skin. Animals 
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(with one exception) were given chloromycetin antibiotic at 
the end of surge:ry (1.5 g/kg, i.m.). Following surge:ry, 
animals were housed in cages with elevated roofs and paper 
towel bedding and allowed to recover for at least one week. 
Animals were habituated to the Plexiglas recording box 
for at least one ten minute session and the appropriate 
stimulating current amplitude and direction were determined 
prior to recording. On recording days, animals were taken from 
the housing room and immediately placed in the recording box. 
Animals were stimulated for a specified length of time at the 
start of each session (two minutes for most animals) in order 
to ensure that proper stimulation was occurring. Perforant 
path evoked dentate gyrus potentials were then recorded for 
ten minutes at .1 Hz using Brainwave software. This was done 
over consecutive days to establish a baseline. On injection 
days, either norepinephrine (10 ~g) dissolved in 0.9% saline 
or saline alone was injected at a volume of 2 ~l over one to 
two minutes. For most animals, evoked potentials were recorded 
for 6 0 minutes following the injection and for two ten minute 
periods at 90 and 180 minutes after the injection. Animals 
were left in the box until the end of the recording sessions. 
OVerall, each animal received one to three injections over a 
period of days or weeks. The order of injections was 
counterbalanced. However, not all animals received saline 
injections since some animals had to be sacrificed before the 
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second (saline) injection was given. 
The behaviour of the animal was recorded at the time that 
each stimulation was delivered ( i . e. eve:ry ten seconds) . 
Behaviour in the interval between stimulations was not 
recorded. Behaviour was recorded manually by the experimenter 
and coded according to the following categories: N - No 
movement- eyes open (i.e. alert immobility), G- Grooming 
behaviour, H - Movement of the head and/or front paws without 
corresponding movement of the body axis, W - Walking or 
locomotion, S -No movement - eyes closed (i.e. sleeping), L -
Rearing on hind legs. This categorization was designed to 
provide a gross description of movement associated with the 
recording sessions, particularly those in which the animal 
received an injection. The means of evoked potential 
parameters associated with each behaviour as well as the 
proportions of each behaviour that occurred were calculated 
prior to and following each injection. 
Prior to sacrifice, the stimulating and recording 
electrode placements were lesioned by electrical current and 
pontamine sky blue was injected into the lateral ventricle 
under Avert in anaesthesia. Dye perfusion of the lateral 
ventricle was verified by visual inspection immediately after 
brain removal. Cannula placement and lesions were visualized 
using differentiated cresyl violet staining. 
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RESULTS 
EXPERIMENT ~ - ACUTE STUDIES 
Population Spike. 
Table 1 shows the effect of saline (vehicle) and various 
doses of NE on the population spike amplitude in the dentate 
gyrus evoked by perforant path stimulation. Following saline 
injection, there were two small magnitude decreases and two 
long delay increases (which were presl.llllabl y unrelated to 
injection since the delay was over 20 minutes). The net effect 
over eight animals did not vary more than one percent from 
baseline, however (see figure 13) . NE reliably produced 
potentiation of popspike amplitude in 13 out of 14 injections 
at the three highest doses. The mean increase was 55. 8%, 
49.8%, and 46.5% at 10, 50, and 100 ~g, respectively. These 
effects typically peaked at between 10 and 20 min post-
injection. Long-lasting (greater than 20 min) effects were 
more often observed at the highest doses. No effects were 
observed at the 1 ~g dose. The threshold dose for potentiation 
of the popspike amplitude is assumed to be between 1 and 10 
~g. This information is presented graphically in Figure 1. The 
1 ~g dose was ineffective while the higher doses produced 
similar potentiation except that the highest doses exhibited 
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shorter delays to significant effects. 
Table 2 and Figure 2 show the effect of ISO (beta-
agonist) on popspike amplitude. The threshold for potentiation 
of the popspike was between 10 and 30 ~g since no consistent 
effect was observed with the 10 ~g dose whereas the popspike 
was always enhanced with both 30 and 60 ~g doses (mean 
increase = 45. 8% and 43.2%, respectively) . The delay to 
significant potentiation was shorter with the 60 ~g dose (mean 
= 7. 2 min) than with the 30 ~g dose (mean = 12.0 min) . A total 
of 8 out of 10 injections at the effective doses resulted in 
long-lasting enhancement. 
Table 3 and Figure 3 detail the effect of PE (alpha-
agonist) on the population spike. The effect of PE was less 
consistent than the NE and ISO effects with 5 significant 
decreases and 6 injections which produced no significant 
effect. However, the most frequent effect observed was 
significant potentiation of the popspike amplitude which 
occurred following 15 of 26 injections. Furthermore, 11 of 
these 15 effects were long-lasting. The mean of the increases 
at 50, 100, 300, and 500 ~g was 56.9%, 35.0%, 63.4%, and 
50.2%, respectively. The threshold dose was probably above 10 
~g since this dose produced 1 decrease and 1 no change and the 
two significant potentiations exhibited a long delay to 
significant effect (mean= 17.5 min). Surprisingly, the two 
doses which produced the clearest potentiation were 50 and 500 
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~g whereas the intervening doses of 100 and 300 ~g were more 
inconsistent . This was demonstrated by shorter delays to 
significant effect (see Table 3) and a larger net deviation 
from baseline (see Figure 3) . The investigator noted that a 
temperature drop of approximately 0. 3 degrees Celsius occurred 
frequently with PE injection, despite attempts to maintain 
stable rectal temperature. However, this decrease was observed 
whether or not the popspike amplitude was increased or 
decreased. 
Figure 4 illustrates three examples of long-lasting 
popspike amplitude potentiation which was followed for at 
least 80 min post-injection. The PE effect was typical in that 
the popspike amplitude returned to baseline within one hour. 
ISO and NE produced effects of varying duration with a 
minority staying elevated near maximal potentiation at the end 
of the recording period (which varied between 3 0 min and 2 
hr). 
EPSP. 
The criterion for injection of saline or drug was a 
stable baseline of population spike amplitude for ten minutes 
prior to injection. The EPSP and popspike onset latency 
baselines were not considered in relation to the time of 
injection. Consequently, some injections were preceded by 
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drifting EPSP baselines and cyclical or drifting popspike 
onset latencies baselines. 
The effect of saline and NE, ISO, and PE on EPSP slope 
are shown in Tables 1, 2, and 3, respectively. Saline and the 
dose of NE (1 ~g) ineffective at producing popspike effects 
produced no clear effect on the EPSP. The NE doses effective 
at producing popspike potentiation produced 3 significant 
increases, 4 significant decreases, and failed to produce a 
significant change on 7 occasions. The selective beta and 
alpha agonists, ISO and PE, produced similar mdxed results at 
doses above the threshold for popspike enhancement. The EPSP 
slope was significantly enhanced following 4 injections, 
significantly diminished following 3 injections, while 
remaining unchanged following 3 injections of ISO. There were 
5 significant increases and 6 significant decreases following 
the injection of PE. The remaining 11 PE injections failed to 
produce a significant change in the EPSP slope. If the 
instances of variable control baselines are removed from the 
analysis, there is still no clear trend in EPSP changes. 
Popspike Onset Latency. 
Tables 1, 2, and 3 also contain the effect of the various 
agonists and vehicle alone onpopspike onset latencies. Saline 
had little effect. With doses above the threshold for popspike 
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effects, NE increased the popspike onset latency on 8 of 14 
occasions and PE increased the popspike onset latency on 15 of 
22 occasions. In contrast, ISO produced a significant decrease 
of popspike onset latency on 8 of 10 occasions. A clear 
majority of these effects were long-lasting with all three 
drugs. If the instances of variable baseline are removed from 
the analysis the picture remains essentially the same. The 
effects of these three drugs on the popspike onset latencies 
were averaged for all doses which were effective at eliciting 
popspike changes and plotted as a percentage of the baseline 
in Figure 5. Clearly, NE and PE produced a similar magnitude 
increase in popspike onset latency whereas ISO produced a 
decrease which occurred over a similar time course. The mean 
of the maximal effect within 30 minutes of injection was 
approximately 6%- for all three drugs. 
Relationship Among Evoked Potential Parameters. 
The types of EPSP and popspike onset latency changes were 
compiled separately for popspike increases, decreases, and 
absence of significant effects. Significant results are 
described only for above threshold doses (as determined by 
their effect on the popspike) of all three drugs. 
When NE produced significant potentiation of the 
popspike, there was 1 EPSP slope increase, 3 decreases, and 
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there was no change on the remaining 5 occasions. The popspike 
onset latency was increased on 6 occasions and remained 
llilchanged on the other 3 occasions. Looking at all three 
parameters simultaneously, on 3 out of 9 occasions the 
popspike amplitude and popspike onset latency were 
significantly increased at the same time that the EPSP slope 
was significantly decreased. 
When ISO produced significant popspike potentiation, the 
EPSP slope was enhanced 2 times, was diminished 3 times, and 
llilderwent no significant change 3 times. The popspike onset 
latency was decreased on all 8 occasions. Looking at all three 
parameters simultaneously, on no occasion (out of a possible 
8) was the popspike amplitude and popspike onset latency 
significantly increased at the same time that the EPSP slope 
was significantly decreased. 
When PE produced significant popspike potentiation, the 
EPSP was decreased on 3/10 occasions while no change occurred 
on the remaining 7 occasions. The popspike onset latency 
increased 9/12 times, decreased once, and remained llilchanged 
twice. When PE injection was followed by significant popspike 
amplitude decreases, both EPSP slope and popspike onset 
latency increased once and exhibited no change on the 
remaining 3 occasions. Finally, when PE had no significant 
effect on the popspike, the EPSP slope increased twice and 
remained llilchanged once, whereas the popspike onset latency 
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increased twice and decreased once. Looking at all three 
parameters simultaneously, on 3 out of 17 occasions the 
pop spike amplitude and popspike onset latency were 
significantly increased at the same time that the EPSP slope 
was significantly decreased. Conversely, there were no 
occasions (out of a possible 17 occasions) where the popspike 
amplitude and popspike onset latency were significantly 
decreased at the same time that the EPSP slope was 
significantly increased. 
Figures 6, 7, and 8 illustrate individual examples of the 
effect of NE, ISO, and PE, respectively, on all three 
parameters of the evoked potential . In these particular 
examples, NE (50 ~g) produced a significant increase in the 
popspike and popspike onset latency with no concomitant change 
in the EPSP. ISO (60 ~g) produced a significant increase in 
the popspike amplitude, a significant decrease in the popspike 
onset latency, with a non-significant increase in the EPSP 
slope. PE (300 ~g) produced a significant increase in the 
popspike amplitude and the popspike onset latency while at the 
same time producing a significant decrease in the EPSP slope. 
These effects were typical of the responses seen to these 
drugs except that the popspike changes were long-lasting which 
was generally typical of the higher doses only. 
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Beta Antagonist. 
The ICV injection of the beta-antagonist Metoprolol in a 
10 ~g dose produced variable results on the popspike 
arrplitude. Table 4 shows that there were 4 significant 
increases with a mean of 70.5% and 7 significant decreases 
with a mean of 25.1%. The remaining 4 MET injections produced 
no significant effect on the popspike arrplitude. No clear 
trend was apparent despite the relatively large number of 
injections performed. The effect of MET on ISO and NE effects 
was only evaluated in experiments where there was no MET 
effect or the MET effect had decayed or plateaued and there 
was a stable baseline for ten minutes before the agonist 
injection. 
The effectiveness of MET as a beta antagonist was 
evaluated by giving ISO (30 ~g) 30 min after MET. Whereas ISO 
alone produced significant long-lasting potentiation following 
all four injections, ISO only facilitated the popspike 
arrplitude on 2 of 4 occasions following MET (Table 4) . On 
those two occasions, the increase was of slightly smaller 
magnitude and somewhat longer delay to effect than without the 
antagonist. As shown in Figure 9, the mean maximal effect 
within 30 min. of ISO application was reduced by more than 50% 
by prior MET injection. This difference was significant (p < 
0.05, Wilcoxon Rank Sum). 
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When injected 30 min. following MET injection, 10 ~g NE 
produced a larger magnitude (mean= 75.5%), shorter delay to 
effect (mean = 4. 7 min.) , significant potentiation of the 
popspike amplitude (3 of 8 cases) than NE alone (Table 4) . 
These increases were all long-lasting compared to an absence 
of long-lasting effects following NE alone. Conversely, the 
popspike amplitude exhibited significant depression in the 
remaining animals (5 of 8 cases), which was always long-
lasting although of a much smaller magnitude (mean decrease = 
36. 6%) . In comparison, NE alone caused significant enhancement 
of popspike amplitude following 4 of 4 injections at a dose of 
10 ~g. Figure 9 shows that the net effect of NE (10 ~g) on the 
popspike following MET injection, averaging across all 
increases and decreases, was near zero compared to a net 
increase of 55.8% following NE alone. This difference was not 
significant, however (p > 0.05, Wilcoxon Rank Sum). 
Alpha Antagonist. 
The injection of PHENT (30 ~g) produced a large magnitude 
(mean= 70. 5%) long-lasting potentiation of popspike amplitude 
in 2 animals whereas in 4 other animals, PHENT injection 
produced no significant change (see Table 5) . At 30 min. post-
injection on the four occasions where there was no significant 
effect due to PHENT itself, PE 50 ~g was injected. The net 
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effect of PE after PHENT was near zero whereas PE alone 
produced a mean maximal potentiation of over 20% 1 as indicated 
in Figure 10. However/ this difference was not significant (p 
> 0.05 1 Wilcoxon Rank Sum). 
Four subsequent injections of PHENT were monitored for 15 
min without any significant change from baseline. At 15 min. 
following PHENT injection/ NE (10 ~g) was injected. Only one 
out of these four injections produced a significant 
potentiation of the popspike compared with all 4 NE (10 ~g) 
injections which were not preceded by antagonist injection 
(see Table 5) . Figure 10 shows that the net effect of NE after 
PHENT was a slight depression of the popspike amplitude 
compared to a mean increase of 55.8% following the same dose 
of NE alone. This difference was significant (p < 0. 05 1 
Wilcoxon Rank Sum) . 
Baseline Measures. 
Appendix I contains the raw means for the popspike 
amplitude during the control period for various drug doses. 
Means were described separately for experiments with popspike 
increases and lack of increases (for drugs where popspike 
changes were variable) . Baseline popspike amplitude did not 
appear to predict response to subsequent drug application 
since the baseline amplitude was larger in cases where the 
32 
popspike amplitude subsequently increased for some drugs and 
smaller for other drugs (only one small n result was 
significant) . 
Appendix II contains the raw means for the popspike onset 
latency during the control period for various drug doses. 
Again, means were described separately for experiments with 
popspike increases and lack of increases (for drugs where 
popspike changes were variable) . Overall, popspike onset 
latency did not differ between cases where the popspike 
amplitude subsequently increased or decreased. However, with 
NE (10 ~g, after MET) and PE (50 ~g, after PHENT), cases with 
subsequent increases had a significantly longer delay to 
popspike onset than cases with subsequent decreases. However, 
whether this represents a real phenomenon is questionable 
since both these instances were small n and there was no 
overall trend. 
EXPERIJv!ENT 2 - CHRONIC STUDIES 
Histology. 
All five animals had clear lesions of the angular bundle 
through the stimulating electrode. Lesion-making attempts with 
the recording electrode failed. Thus vertical positioning was 
unknown. Electrode tracts verified medial-lateral placement in 
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the dentate gyrus. Two perforant path evoked-dentate gyrus 
profiles had the classic granule cell layer shape. Three other 
profiles had slightly different shapes. They were classified 
as granule cell layer profiles on the basis of their latencies 
to popspike onset and popspike peak, which were intermediate 
between the latencies exhibited by the other two profiles. 
Pontamine Sky Blue injection prior to sacrifice revealed 
dye clearly through the lateral ventricles in three animals 
and dye slightly above the ventricles in 1 animal. On 1 
animal, the cap was lifted irrmediately prior to sacrifice 
preventing verification of cannula placement. In some animals, 
one week had elapsed between the last rev injection and 
sacrifice (and dye injection) and animals were not sacrificed 
until there was some visual or physiological evidence of skull 
cap lifting. Therefore, neither positive nor negative dye 
results are conclusive of cannula placement at the time of 
injection. Furthermore, the internal cannula may take varying 
tracks on successive injections since the guide cannula was 
much larger gauge than the internal cannula in order to 
facilitate placement of the internal cannula during recording 
sessions. 
Population Spike. 
The evoked potential was monitored for a 10 min. 
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baseline, and from 0 - 60, 90 - 100, and 180 - 190 min post-
injection. The results were analyzed as 10 min. means. For 
equivalence to acute studies, the maximum effect on one min. 
means within 30 min. post-injection was also reported. 
Saline injection failed to produce significant 
potentiation of the popspike within 30 min. or at any of the 
sarrpled ten minute intervals within 3 hr. (n=2) . Table 6 lists 
the effect of saline on one min. means within 30 min. 
following the injection. 
In contrast, NE 10 ~g injection always produced 
significant potentiation of the popspike arrplitude for at 
least two ten minute intervals (6 injections, 4 animals) . This 
significant facilitation began within the first two ten minute 
intervals post injection on all but one occasion. There was 
only one ten min. mean that was significantly decreased and 
this was followed by a significant potentiation. Looking at 
one minute means, Table 6 shows that there were 4 long-lasting 
and 1 short-lasting significant increases within 30 minutes 
post injection (mean = 46. 0%) . There was 1 significant 
decrease (which was followed by a significant increase at 90 
and 180 min.). Figure 11 plots the popspike arrplitude at 10 
min. intervals for all 6 NE 10 ~g injections. Four strong 
long-lasting increases are clearly shown. Note that all 
significant increases returned to baseline except for the case 
where recording was terminated at 30 min. post-injection. (The 
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recording periods differ slightly as the recording period 
protocol was not adopted until after the first two 
injections.) 
EPSP. 
Following saline injection, there were two long delay (40 
and 90 min) decreases in EPSP slope which persisted for two 10 
min. intervals. NE (10 Jlg) produced mixed results on the EPSP 
slope. There were 3 significant increases, 1 significant 
decrease, and 3 biphasic effects (significant decreases 
followed by significant increases) . 
Popspike and EPSP together. 
Ten min. means on which significant NE induced popspike 
facilitation was recorded were analyzed for corresponding 
changes in the EPSP. No correspondence between popspike and 
EPSP changes was found. Surrming across all animals, during 40% 
of the time intervals which exhibited significant popspike 
facilitation, the EPSP slope was significantly increased. In 
contrast, the EPSP slope was significantly decreased 35% of 
the time and exhibited no significant change on the remaining 
25% of the time. Figure 12 shows an example of the effect of 
NE on both parameters in a single rat. In this instance, there 
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was little change in the EPSP while the popspike was enhanced. 
However, when the popspike subsequently decreased, the EPSP 
increased at the same time. 
C~ison Of Acute and Chronic Effects. 
Table 6 contains the results for the effect of a NE 10 ~g 
injection on popspike arrplitude in both anaesthetized and 
awake animals. The results are analyzed as means of the 
maximum effect within 30 min post-injection. NE (10 ~g) 
produced a mean maximal increase of 55.8% that was never long-
lasting in 4 anaesthetized animals. NE produced a mean maximum 
increase of 46.0% that was long-lasting (greater than 20 min.) 
in 4 of 5 awake animals. The popspike amplitude was 
significantly depressed in one animal, a short-lasting effect. 
Figure 13 plots the effect of NE 10 ~g injection on the 
popspike arrplitude, analyzed as ten min means. Saline failed 
to elicit any net change in the popspike arrplitude in either 
anaesthetized or awake animals (n=8, n=2, respectively) . The 
popspike arrplitude was facilitated in both anaesthetized and 
awake animals to a similar degree (n=4, n=5, respectively). 
Figure 14 plots the NE 10 ~g effect on EPSP slope, 
analyzed as ten min. means. Again, saline failed to produce 
any net change. The EPSP slope was only slightly altered 
following NE injection. The net effect was a small magnitude 
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decrease in anaesthetized animals and a small magnitude 
increase in awake animals. 
Population Spike and Corresponding Behaviour. 
The behaviour of the rat was recorded while each evoked 
potential was elicited. This was done to determine if any 
popspike changes observed were correlated with a particular 
behaviour type. There was no consistent difference in popspike 
size associated with behaviour type following NE injection. 
Figure 15 shows one example of significant NE potentiation of 
the popspike. All popspikes were potentiated regardless of the 
behaviour type associated with the popspike. An alternative 
way of examining this is to restrict the analysis to the 
predominant type of behaviour exhibited in the ten minute 
control period. This analysis was performed in a subset of NE 
injections and showed that the mean popspike amplitude 
associated with no movement, eyes open was greater following 
the injection than during the control period to a similar 
degree as the overall effect. In one case, the potentiation of 
the popspike amplitude associated with no movement - eyes open 
was 28.3% compared with an overall increase of 23.9% during 
the first hour (figure 11, open circles) . In the second, the 
potentiation associated with no movement - eyes open was 27. 3% 
compared to an overall increase of 23.4% (figure 11, closed 
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triangles) . 
The popspike amplitude associated with each behaviour 
type was also examined over a period of days during the ten 
minute baseline recording period. Two such examples are 
illustrated in figures 16 and 17. Figure 16 shows that the 
popspike amplitude associated with no movement - eyes closed 
was lower than that associated with no movement - eyes open on 
7 out of 10 days but this effect was not significant (p > 
0.05, two-tailed, paired t-test). Figure 17 shows that the 
popspike amplitude associated with grooming was larger on two 
out of three baseline periods and larger following NE 10 
injection (last three points) than the popspike amplitude 
associated with no movement - eyes open. An earlier period of 
recording in the same animal (not shown) exhibited lower 
popspike amplitude associated with grooming than with no 
movement - eyes open on 2 out of 3 days when both behaviours 
were present. Overall, the difference between popspike 
amplitude associated with grooming and no movement - eyes open 
was not significant (p > 0.05, two-tailed, paired t-test). 
Therefore it appears there was no clear association between 
behaviour and popspike amplitude during either the baseline 
period or subsequent to drug injection. 
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Norepinephrine Effects On Behaviour. 
Table 7 details the effect of saline and NE 10 jlg 
injection on the proportions of each behaviour type exhibited 
within 30 minutes of ICV injection. Behaviour was analyzed in 
ten min. bins. Following saline injection there was a decrease 
in no movement - eyes open and an increase in grooming and 
walking in the first ten min. and an increase in no movement -
eyes closed in the last ten min. In the ten min. following NE 
injection, there was a larger decrease in no movement - eyes 
open, a decrease in grooming, a large increase in walking 
behaviour, and the appearance of standing on hind legs and 
chewing. Similarly to saline, there was an increase in no 
movement - eyes closed behaviour in the last ten min. bin. 
OVerall, it is unlikely that the behavioural effect of NE 
(particularly, the increase in walking) was responsible for 
the increase in popspike amplitude since there was no 
association between behaviour and popspike amplitude. 
Agonists. 
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DISCUSSION 
ICV injection of Norepinephrine reliably produced a 
potentiation of the perforant path-evoked potential in the 
dentate gyrus of the anaesthetized rat consistent with 
previous in vivo (Neuman and Harley, 1983; Winson and Dahl, 
1985) and in vitro (Lacaille and Harley, 1985) reports. The 
enhancement was long-lasting in 6 of 13 experiments, more 
frequently so at higher doses. The beta agonist ISO mimicked 
the effect of NE and was more likely than NE to produce long-
lasting enhancement (8 of 10 experiments) . This agrees with 
the in vitro findings of Lacaille and Harley (1985) where ISO 
superfusion always produced an enhancement. It contrasts with 
Winson and Dahl (1985) who reported a decrease of popspike 
amplitude during iontophoretic application of ISO in vivo. The 
alpha agonist PE also caused a potentiation of popspike 
amplitude in a majority of experiments. However, the effect of 
PE was less consistent than that of ISO and included decreases 
in a minority of experiments. These findings, although less 
reliable than the beta enhancement, lend some credence to the 
earlier report of alpha induced potentiation following 
iontophoresis in vivo (Winson and Dahl, 1985) . It is notable 
that one in vitro study which concluded that NE potentiation 
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was beta me~iated did find enhancement following PE 
superfusion in_ 29% of experiments (Lacaille and Harley, 1985) . 
To summa~ize from the agonist results in anaesthetized 
rats, NE prod.-uced a potentiation of the popspike that was 
dose-dependent in duration but not magnitude. Both ISO and PE 
caused popspik:e potentiation although the ISO effect was more 
reliable, resembling the previous in vitro pharmacological 
study. 
Antagonists. 
Mixed results were obtained in experiments where 
antagonists were introduced prior to NE injection. NE produced 
an enhancement in only 3 of 8 experiments following lYlET (beta 
antagonist) i:njection. However, these increases were all 
larger and longer lasting than those following NE alone. 
Furthermore, the other 5 experiments showed decreases to NE 
injected afte~ MET. On post hoc examination, it appears that 
two separate ~pulations of results are occurring. Appendices 
I and II show that the popspikes that increased were smaller 
(not significcunt) and of longer latency (significant) than 
those that were blocked by prior application of MET. The 
overall diffe~ence between NE alone and following MET was not 
significant, !Jowever. In contrast, the alpha antagonist PHENT 
did signific~tly block the NE induced potentiation. 
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Previous in vitro studies have reported the enhancement 
effect of NE could be blocked by beta antagonists (Lacaille 
and Harley, 1985; Stanton and Sarvey, 1985a) but not alpha 
antagonists (Lacaille and Harley, 1985) . As well, NE and PHENT 
produced a greater enhancement than NE alone (Dahl and Sarvey, 
1989) . Furthermore, potentiation by release of endogenous NE 
has also been antagonized through beta receptor antagonists 
(Harley and Milway, 1986; Harley and Evans, 1988; Babstock and 
Harley, 1992) although alpha antagonists have never been tried 
in vivo. However, the effect of the beta antagonist in vivo 
was often an attenuation of the NE effect rather than a 
complete block. 
In this study, the failure of the beta antagonist to 
block NE potentiation in all experiments could be due to too 
low a dose or too long a delay between antagonist and NE 
administration since it failed to completely block ISO induced 
potentiation on all occasions (it did significantly antagonize 
the ISO effect, however) . Higher doses or shorter delays were 
problematic since MET frequently had effects of its own and a 
delay was necessary to ensure that MET induced changes would 
not occur. The alpha antagonist more frequently blocked both 
PE and NE induced potentiation suggesting an effective dose 
and delay were employed. 
To surrmarize, 
evidence suggesting 
the present study presents preliminary 
alpha antagonists may block the NE 
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potentiation effect, contrary to Lacaille and Harley (1985), 
whereas beta receptor antagonists may not do so as 
consistently as previously thought. Further in vivo 
pharmacological studies are clearly required. Given the 
variability in the present results with beta antagonists, 
conducting more experiments using the current protocol is of 
dubious value. A future elaboration of the current study might 
include examination of the effectiveness of MET using a 
narrower range of popspike sizes and latencies. The use of 
beta antagonists other than MET would also be helpful to 
evaluate the reliability of beta blockade of the potentiation 
with exogenously applied NE, in vivo. 
NE Effects in Chronic Animals. 
Intracerebroventricular administration of NE in the 
awake, behaving animal produced an enhancement of the 
population spike which was virtually indistinguishable from 
the effect of the same dosage in the anaesthetized animal. 
This result is encouraging since the bulk of NE studies have 
been done in the anaesthetized preparation. The present report 
of potentiation induced by exogenous NE application in the 
awake animal corresponds well with the report of Klukowski 
(1993) of potentiation of the popspike amplitude in awake 
animals following glutamate injection in the vicinity of the 
44 
locus coeruleus in order to stimulate endogenous NE release. 
While some of the icv injections produced a long-lasting 
(greater than 30 minutes) enhancement, no effect persisted for 
longer than 1 hour. It should be noted that only the lowest 
effective dose of NE from experiments in the anaesthetized rat 
was used. In the anaesthetized preparation, higher NE doses 
and the selective beta agonist ISO more frequently produced 
long-lasting potentiation. A future study employing these 
doses is needed in order to evaluate the length of time that 
the potentiation may last before decay. This is particulary 
relevant in reference to possible involvement of NE in 
cellular mechanisms of memory. 
Mechanisms of Potentiation. 
Any changes initiated by NE presumably involve second 
messenger activation. The beta-mediated NE effect has been 
documented as activating cAMP (cyclic Adenosine 
monophosphate). Stanton and Sarvey (1985b) showed that NE 
superfusion produced a 3-fold rise in cAMP levels in the 
dentate gyrus in vitro. Furthermore, another slice study by 
the same authors showed that the protein synthesis inhibitor, 
emetine, blocked the long-lasting facilitation induced by NE 
(Stanton and Sarvey, 1985a) . Preincubation with forskolin, an 
adenylate cyclase activator, shifted the dose response curve 
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to the left and the potentiation was blocked by propranolol 
and MET leading the authors to conclude that the NE effect was 
mediated by beta-1 stimulation of adenylate cyclase. A 
presynaptic effect is also possible since NE has been shown to 
enhance a K+ induced, Ca2+ dependant release of glutamate in 
the dentate gyrus in vitro (Lynch and Bliss, 1986) . This 
effect was mimicked by isoprenaline (beta agonist) but not PE 
and was partially antagonized by propranolol but not PHENT. 
The focus on beta mediation of NE effects has led to an 
absence of studies concerning NE effects on alpha receptor 
mediated second messengers. However, it is possible that alpha 
receptor stimulation of inositol triphosphate accumulation or 
effects on the beta mediated accumulation of cAMP may be 
involved in the NE potentiation phenomenon. In slices from 
cerebral cortex, NE caused a larger increase in cAMP than ISO 
and the addition of alpha-1 agonists elevated the cAMP 
response to ISO to the level seen with NE alone. In addition, 
alpha-1 agonists caused a large increase in inositol 
triphosphate accumulation (Atkinson and Minneman, 1991). 
Mailleux et al. (1991) showed high levels of inositol 1,4,5-
triphosphate 3-kinase mRNA exist in granule cells of the 
dentate gyrus. Alpha mediated increases in inositol 
triphosphate might serve a helper function by increasing 
calcium levels after NE application, a possibility suggested 
by the shorter term nature of PE potentiation. 
46 
Summary of Pharmacology. 
To summarize, results of the icv pharmacological 
investigation of NE potentiation of dentate gyrus popspikes 
suggest a possible involvement of both beta and alpha 
receptors. Alpha agonists frequently enhanced the popspike 
amplitude, although not as reliably as beta agonists or NE 
itself. However, alpha and beta receptor effects do not appear 
to sum since they both produced potentiation of the same 
magnitude as NE itself. As well, beta and alpha antagonists 
both blocked NE potentiation in a majority but not all 
experiments (only the alpha antagonism was significant, 
however) . This picture of receptor mediation would bring NE 
effects in the hippocampus more in line with other brain areas 
where alpha receptors generally potentiate excitation. The 
suggestion of both beta and alpha mediated enhancement of the 
popspike lies somewhat intermediate between the findings of a 
previous in vitro study suggesting beta mediation (Lacaille 
and Harley, 1985) and a previous in vivo study suggesting 
alpha mediation (Winson and Dahl, 1985) . 
Temperature Effects in Acute Animals. 
There are alternate explanations for some of the 
phenomena occurring in this study. It is possible that an 
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alpha mediated drop in temperature is responsible for the 
potentiation frequently seen. Body temperature was generally 
held constant. However, sharp drops in temperature often 
occurred after PE injections. This temperature drop was 
prevented from exceeding 0.3 oc by increasing the flow of hot 
water through the blanket underneath the animal . However, this 
might not have precluded a larger drop in brain temperature. 
Moser, Mathiesen and Andersen (1993) report that lower brain 
temperatures in awake rats produced larger popspikes, 
increased latency to popspike and decreased EPSP slope 
(positive slope) . The converse was true of increased brain 
temperatures which would arise from increased motor activity. 
If the PE enhancement of popspike in the present study was due 
to an alpha mediated drop in brain temperature, we would 
expect a concurrent increase in latency and decrease in EPSP 
slope. In the cases where PE produced significant enhancement 
of the popspike, the EPSP decreased on only 3 of 10 occasions 
whereas the popspike onset latency was almost always increased 
(delayed) . The EPSP changes do not support a temperature 
decrease whereas the latency changes are consistent with such 
a mechanism. Clearly, future studies should involve monitoring 
brain temperature. It should be noted, however, that the Dahl 
and Winson (1985) iontophoretic study presumably did not 
involve temperature changes but also reported an alpha 
mediated enhancement . As well, the blocking of NE enhancement 
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by an alpha antagonist is more difficult to reconcile by means 
of a temperature drop explanation. It should also be noted 
that the. changes in brain temperature in the Moser et al . 
(1993) study were very large (about 5 °C) . Furthermore, the 
magnitude of the latency changes (6%) was small in the present 
study relative to the change in popspike amplitude 
(approximately 50%) whereas the temperature induced changes in 
popspike amplitude and onset latency were of similar magnitude 
in the Moser et al. (1993) report. 
Other Alternate Explanations in Acute Animals. 
Another concern with intraventricular administration of 
drugs is the possibility of effects on non-hippocampal 
structures. Harley et al. (1993) performed icv injections of 
NE while recording popspikes from the hippocampus of 
anaesthetized rats employing similar methodology to this 
study. In vivo microdialysis revealed that NE levels increased 
markedly in the hippocampus following NE injection into the 
lateral ventricle . More irnportantl y, substantial NE levels in 
the hippocampus appeared to be critical for NE potentiation to 
occur. When NE was injected into the medial ventricular 
system, NE levels were presumably elevated in non-hippocampal 
areas including the hypothalamus, but no potentiation of the 
popspike occurred. This supports the notion of direct effects 
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of NE upon the hippocampus although indirect effects of the 
various agonists cannot be ruled out. 
This line of reasoning would tend to discount the 
involvement of blood pressure changes or the autonomic ne:rvous 
system in the effect of NE on the dentate gyrus evoked 
potential. However 1 vasoconstriction or effects on the release 
of other neurotransmitters or neuropeptides could be involved 
in the NE induced potentiation within the hippocampus itself. 
The former explanation was not assessed and there is little 
experimental work which addresses the effect of 
vasoconstriction on the evoked potential. The latter 
explanation does not discount the present work since this 
study does not necessarily imply a direct cellular effect of 
NE on granule cell neurons. The effect may be due to effects 
on inhibitory neurons or the release of other substances. 
Al te.rna te Explanations in Chronic Animals. 
In awake 1 behaving rats 1 an additional source of popspike 
variability is changes in behavioral state of the animal. 
Changes in behavioral state with removal of the animal from 
the home cage may occur. As well 1 animals might experience a 
drop in body temperature after prolonged immobility in the 
metal and Plexiglas recording chamber. In order to exclude the 
possibility that effects were occurring because of these 
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sources and not NE itself, recordings were taken from animals 
at a set time after removal from the home cage. Furthermore, 
animals were recorded after injection of saline at the same 
time as NE injection would occur without any resulting 
popspike amplitude changes. 
Another source of behavioral interference with the 
popspike amplitude would occur if handling during the 
injection or the NE injection itself produced effects on 
behaviour which subsequently produced changes on the popspike. 
Hargreaves et al. (1990) have reported that popspikes were 
smaller during walking behaviour rather than during 
immobility. Winson and Azbug (1978) reported that the popspike 
was greater in magnitude during slow wave sleep than during 
the still, alert condition whereas the popspikes during REM 
sleep and voluntary movement were intermediate in amplitude 
and also more variable. Buzsaki et al. (1981) reported that 
the rank order of popspike amplitude during different 
behaviours was drinking > grooming > pressing > running, 
although only the difference between drinking and running was 
significant. 
Behavioral effects due to handling or vehicle injection 
are unlikely to be responsible for the potentiation since no 
enhancement followed saline injection. Behavioral changes 
after saline were also relatively minor. NE itself appeared to 
cause large changes in behaviour; it mainly increased the 
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amount of locomotory behaviour. Is it possible that the NE 
induced behavioral changes are responsible for the popspike 
enhancement? This appears unlikely since an increase in 
walking or voluntary movement relative to immobility or the 
still, alert state should decrease the popspike according to 
Hargreaves et al. (1990) and Winson and Azbug (1978). This 
makes intuitive sense since an increase in activity would 
increase muscular activity thus increasing brain temperature 
which would have the opposite effect of depressing the 
popspike (Moser et al., 1993). This explanation also appears 
unlikely since the magnitude of popspike amplitude was not 
clearly associated with any particular behaviour. Popspike 
amplitude was elevated following NE injection during all types 
of behaviour. Finally, and perhaps most convincingly, the 
magnitude and time course of NE potentiation was virtually 
indistinguishable from the effect of the same dose in the 
anaesthetized animal where behavioral modification of the 
popspike was not possible. 
Behavioral Effects in Chronic Animals. 
The behavioral effects of icv NE in the awake animals 
consisted mainly of increases in locomotory behaviour and 
decreases in grooming and alert immobility (no movement, eyes 
open) . In contrast, saline injections were followed by a 
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smaller decrease in the proportion of time spent in alert 
irrmobility and an increase in grooming. This corresponds well 
with previous reports that NE injection in the lateral 
ventricles or hippocampus produces an increase in exploratory 
behaviour. Herman (1973) reported that 10 and 50 Jlg icv doses 
of NE produced a significant increase in walking and decrease 
in irrmobility. Flicker and Geyer (1982) reported that 30 to 
300 ng doses of a racemic mixture of NE continuously infused 
directly into the hippocampus over 40 minutes produced an 
increase in di versi ve exploration manifested as an increase in 
centre entries, hole poking and rearing behaviour without a 
corresponding increase in overall motor behaviour. Segal and 
Mandell (1970) reported that the racemic mixture of NE infused 
icv at a rate of 10 or 60 Jlg per hour for two hours produced 
an increase in general activity and locomotion without 
evidence of bizarre behaviour patterns such as circling or 
ataxia. It is interesting to note that some instances of 
ataxia, facial fasciculation, mastication and postural 
abnormalities were recorded in this study following NE 
injection in the awake animal. This may be because of the 
larger bolus received during two minutes rather than 
continuous infusion. Klukowski (1993) also noted the 
occurrence of postural asymmetries and facial fasciculation 
following glutamate injection in the area of the locus 
coeruleus. Weiss et al. (1986) reported a contrasting finding. 
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A 10 flg icv dose of the pure isomer of NE produced inactivity 
on a swim test without changing spontaneous activity levels. 
Oddly, both alpha and beta agonists caused inactivity on the 
swim test and a decrease in spontaneous activity. In addition 
to the correspondence between behavioral effects, these 
studies also used icv doses in the range of those employed 
here. This makes it possible to compare the effects of icv NE 
on electrophysiology with the literature concerning behavioral 
changes. 
EPSP Slope. 
EPSP changes were variable following NE and agonist 
infusions in the lateral ventricle in the anaesthetized 
preparation. There were a similar number of increases and 
decreases in EPSP slope while the most common effect was an 
absence of change. This contrasts with slice experiments 
where the EPSP was frequently facilitated (Lacaille and 
Harley, 1985; Burgard, Decker and Sarvey, 1989; Stanton and 
Sarvey, 1987) and agrees with most in vivo reports of 
inconsistent effects of NE on the EPSP slope (Neuman and 
Harley, 1983; Dahl and Winson, 1985; Winson and Dahl, 1985; 
Harley, Milway and Lacaille, 1989; Washburn and Moises, 1989; 
Babstock and Harley, 1992) . Our results do not concur with the 
minority of in vivo studies which found EPSP increases on a 
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majority of experiments (Harley and Milway, 1986; Harley and 
Evans, 1988) . Overall, it seems clear that the picture of EPSP 
modulation presented in the slice does not apply to the intact 
animal. This calls into question whether the picture of solely 
beta mediated popspike enhancement seen in vitro applies to 
the intact animal. 
An alternate methodological explanation could be that 
slice studies involve more selective activation of medial 
perforant path fibres whereas in vivo experiments involve 
stimulation of mixed medial and lateral perforant path fibres. 
Dahl and Sarvey (1989) demonstrated that NE selectively 
potentiates medial perforant path evoked EPSP's while 
depressing EPSP's elicited by lateral perforant path 
stimulation. Work in progress in this laboratory concerning 
the effects of in vivo l?GI stirrn1lation on the popspikes 
selectively activated by either lateral or medial inputs 
should shed some light on this issue. It is also unclear if 
changes in the dendritic EPSP would be reflected in the 
positive EPSP recorded at the granule cell layer (Winson and 
Dahl, 1985, Dahl and Winson, 1985) . This is an important 
consideration since, as stated in the introduction, most in 
vivo studies recorded from the cell bodies whereas in vitro 
studies recorded from the dendrites. 
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Popspike Onset Latency. 
Changes in popspike onset latency were more consistent 
and notably included differential effects depending upon the 
receptor activated. NE and the alpha agonist PE produced a 
longer delay to the onset of the popspike whereas the beta 
agonist ISO caused a faster popspike onset latency to occur. 
The two reports of consistent latency changes have been 
decreases (Lacaille and Harley/ 1985; Babstock and Harley/ 
1992) which is consistent with the effect of ISO in our 
anaesthetized animals. Whether the increases in latency 
following NE and PE infusion are due to a differential effect 
of alpha and beta receptors on popspike arrplitude or due to an 
alpha mediated terrperature decrease remains to be determined. 
Relevance of NE Effects to Information Processing. 
The question that naturally arises given the consistent 
NE enhancement of popspike arrplitude in the dentate gyrus is 
what does this effect represent for normal processing in the 
mamnalian brain? Winson and Dahl (1985) propose that the 
function of NE in the dentate gyrus is "modulation of granule 
cell excitability with behavioral state" (p. 505). According 
to this view 1 when the animal is alert the LC is more active 
causing more NE release in the dentate gyrus which would lead 
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to better information transfer through the hippocampus. 
Obviously, it would be advantageous to have better information 
transfer during exploration and food getting than during 
resting, etc. This could also explain why memory of dreams 
(which typically occur during periods of LC inactivity) or 
events during hypnosis is poor compared to normal functioning. 
It has been suggested that NE may act to decrease 
spontaneous activity in the hippocampus while at the same time 
increasing evoked activity. i . e. , NE may facilitate 
information transmission through the hippocampus by increasing 
the signal to noise ratio (see Harley, 1987) . 
The finding of simultaneous medial perforant path 
potentiation and lateral perforant path depression of evoked 
popspikes suggests another possible interpretation of NE's 
function in the dentate gyrus (Dahl and Sarvey, 1989) . They 
conclude that "an NE-induced enhancement of medial PP 
activation would presumably strengthen multimodal input to 
granule cells over the concurrently depressed olfactory and 
subcortical input via the lateral PP." (p. 4779). "With 
respect to learning and memory, NE may selectively enhance 
specific intracortical circuits against a background of NE-
induced suppression of neuronal activity." (p. 4779). The 
medial perforant path carries non-olfactory sensory 
information from the cortex whereas the lateral perforant path 
carries information from olfactory areas and sub-cortical 
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structures (Cragg, 1961; Krettek and Price, 1977). Lastly, NE 
released in the dentate gyrus may be an important component of 
memory formation in the mammalian brain through its direct 
enhancement of information transmission in the first stage of 
the hippocampal circuit which could promote the formation of 
more permanent changes in the cortex. The NE potentiation 
phenomenon might be incorporated into the Buzsaki theory of 
hippocampal fnnctioning (Buzsaki, 1989; Buzsaki and Czeh, 
1992) by temporarily strengthening connections of granule 
cells nntil the sharp wave stage during sleep, immobility, 
etc. Furthermore, it would act to sharpen the representation 
of novel stimuli and sharpen the signal to noise ratio to 
prevent the activation of a too diffuse net in CA3 of the 
hippocampus. 
Swnmary and Future Experiments. 
The results of this study support a role for beta 
receptor activation in NE potentiation of perforant path 
evoked -dentate gyrus population spikes. The results also 
suggest alpha receptors may promote potentiation. While 
temperature effects need to be more critically assessed, the 
effect of alpha antagonists supports this inference. The 
ability of either agonist to promote NE effects and the lack 
of evidence of summation effects suggests that both receptors 
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converge on the same mechanisms of plasticity. Given the 
suggestion of alpha receptor involvement in this study, 
further studies of LC and PGI activation should include the 
use of alpha as well as beta antagonists. As well, further in 
vivo studies of the pharmacology of NE potentiation are 
necessary. 
Icv NE offers a promising route to study NE induced long-
lasting potentiation in the in vivo preparation. Potentiation 
has been clearly demonstrated with exogenous NE application in 
the awake, behaving animal. A future study in the awake animal 
should infuse higher NE doses and the beta agonist, ISO, to 
assess the long term profile of popspike potentiation over 
hours or days. While progress has been made, further 
experiments are needed to clarify the role of NE in 
hippocampal information transmission. 
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APPENDIX I 
Popspike amplitude raw means and standard deviations for the ten 
minute control period prior to drug injections. Change in popspike represents 
significant deviations from baseline that occurred after drug injection. 
Drug Dose Change in Mean St. Dev. n 
Pops pike (uV) (uV) 
saline All 3298.0 2138.8 8 
NE 1 ug All 4770.1 1536.9 4 
NE 10 ug All 1889.9 440.5 4 
NE 50 ug All 2701 .5 2049.0 4 
NE 100 ug All 3713.9 2798.4 6 
ISO 10 ug All 2447.3 445.2 4 
ISO 30 ug All 2864.9 2098.8 4 
ISO 60 ug All 4953.7 3331.2 6 
PE 10 ug All 3271 .5 1010.5 4 
PE 50 ug All 1555.1 332.3 4 
PE 100 ug All 5435.5 1476.4 4 
PE 300 ug All 4360.5 2001.3 8 
PE 500 ug All 3760.1 1420.4 6 
PE - all doses Increase 3880.5 1780.4 15 
No Increase 3662.3 1946.1 11 
MET 10 ug Increase 4339.3 3095.7 4 
No Increase 5809.6 4026.9 11 
All 5417.2 3753.3 15 
ISO 30 ug ( after MET) Increase 5081.8 3390.4 2 
No Increase 8991.6 5769.5 2 
All 7036.7 4474.7 4 
NE 10 ug (after MET) Increase 2032.2 806.2 3 
No Increase 6189.2 4100.8 5 
All 4630.4 3797.9 8 
PHENT 30 ug Increase 1394.0 2.0 2 
No Increase 5488.4 3241.9 4 
All 4123.6 3282.7 6 
PE 50 ug (after PHENT) Increase 7778.2 1 
No Increase 4007.8 2820.9 3 
All 4950.4 2976.4 4 
NE 10 ug (after PHENT) * Increase 7220.6 1 
No Increase 2155.6 1320.8 3 
All 3421 .8 2752.6 4 
* p < 0.05, two sample t-test (increases compared to no increases) 
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APPENDIX II 
Popspike onset latency raw means and standard deviations for the ten 
minute control period prior to drug injections. Change in popspike represents 
significant deviations from baseline that occurred after drug injection. 
Drug Dose Change in Mean St. Dev. n 
Pops pike (us) (us) 
saline All 3350.8 239.2 8 
NE 1 ug All 3527.5 244.9 4 
NE 10 ug All 3346.3 295.8 4 
NE 50 ug All 3595.6 443.5 4 
NE 100 ug All 3594.3 198.0 6 
ISO 10 ug All 3412.3 216.3 4 
ISO 30 ug All 3654.8 476.4 4 
ISO 60 ug All 3479.6 435.0 6 
PE 10 ug All 3655.7 279.5 4 
PE 50 ug All 3498.3 631.5 4 
PE 100 ug All 3179.0 272.9 4 
PE 300 ug All 3492.0 491.9 8 
PE 500 ug All 3421.2 373.7 6 
PE - all doses Increase 3459.1 487.0 15 
No Increase 3446.2 348.8 11 
MET 10 ug Increase 3418.6 187.2 4 
No Increase 3458.6 321.3 11 
All 3447.9 285.6 15 
ISO 30 ug (after MET) Increase 3296.2 38.9 2 
No Increase 3310.7 119.3 2 
All 3303.4 72.9 4 
NE 10 ug (after MET)* Increase 3626.9 65.5 3 
No Increase 3325.5 133.1 5 
All 3438.5 188.9 8 
PHENT 30 ug Increase 3536.0 154.1 2 
No Increase 3556.3 178.6 4 
All 3549.5 154.9 6 
PE 50 ug (after PHENT)* Increase 3877.0 1 
No Increase 3507.3 36.3 3 
All 3599.8 187.2 4 
NE 10 ug (after PHENT) Increase 3429.0 1 
No Increase 3393.7 276.8 3 
All 3402.5 226.7 4 
* p < 0.05, two sample t-test (increases compared to no increases) 
... .... . 
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APPENDIX III 
~les of evoked potentials recorded chronically from each 
of f1ve awake, behaving rats (Experiment II) . 
J 
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Table 1: The effect of saline and varying doses of NE on 
popspike amplitude, EPSP slope, and popspike onset latency 
following ICV injection in the anaesthetized rat. MEAN 
represents an average of the maximal change within 3 0 minutes 
post-injection that differs significantly from baseline. DElAY 
refers to an average of the time from injection until a 
significant effect. The number of significant effects of 
duration less than or greater than 20 minutes is listed. All 
doses are in ug. 
INCREASE DECREASE NO CHANGE 
PARAMETER DOSE MEAN DELAY n<20 n>20 MEAN DELAY n<20 n>20 n/N 
(%) (min) min min (%) (min) min min 
NaCI 43.9 21 .5 1 1 16.4 6.0 1 1 4/8 
1 12.4 25.0 1 3/4 
POPSPIKE 10 55.8 9.3 4 0/4 
50 49.8 6.3 1 2 1/4 
100 46.5 4.5 2 4 0/6 
NaCI 18.0 6.8 1 3 11 .6 11 .0 2 2/8 
1 10.8 7.0 1 1 2/4 
EPSP 10 16.0 1.5 2 2/4 
50 4/4 
100 13.3 11 .0 1 2 12.0 3.0 1 1 1/4 
NaCI 3.8 11 .5 2 6/8 
1 2.5 16.0 2 1 1/4 
LATENCY 10 7.0 4.5 1 1 2/4 
50 6.1 5.7 1 2 1/4 
100 6.0 4.7 1 2 2.3 4.0 1 2/6 
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Table 2: The effect of varying doses of ISO (beta-agonist) on 
popspike amplitude, EPSP slope, and popspike onset latency 
following ICV injection in the anaesthetized rat. MEAN 
represents an average of the maximal change within 3 0 minutes 
post-injection that differs significantly from baseline. DEIAY 
refers to an average of the time from injection until a 
significant effect. The number of significant effects of 
duration less than or greater than 20 minutes is listed. All 
doses are in ug. 
INCREASE DECREASE NO CHANGE 
PARAMETER DOSE MEAN DELAY n<20 n>20 MEAN DELAY n<20 n>20 n/N 
(%) (min) min min (%) (min) min min 
10 18.3 2.0 1 31 .7 3.0 1 2/4 
POPS PIKE 30 45.8 12.0 4 0/4 
60 43.2 7.2 2 4 0/6 
10 9.9 15.5 1 1 11.2 3.0 1 1/4 
EPSP 30 9.6 20.0 1 14.4 5.0 1 1 1/4 
60 13.3 5.7 1 2 41 .8 2.0 1 2/6 
10 5.5 13.3 3 1/4 
LATENCY 30 3.2 1.0 1 6.5 11 .7 3 0/4 
60 5.5 7.0 1 6.3 3.2 1 4 0/6 
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Table 3: The effect of varying doses of PE (alpha-agonist) on 
popspike amplitude, EPSP slope, and popspike onset latency 
following rev injection in the anaesthetized rat . MEAN 
represents an average of the maximal change within 3 0 minutes 
post-injection that differs significantly from baseline. DElAY 
refers to an average of the time from injection until a 
significant effect. The number of significant effects of 
duration less than or greater than 20 minutes is listed. All 
doses are in ug. 
INCREASE DECREASE NO CHANGE 
PARAMETER DOSE MEAN DELAY n<20 n>20 MEAN DELAY n<20 n>20 n/N 
(%) (min) min min (%) (min) min min 
10 43.6 17.5 2 2/4 
50 56.9 3.5 2 19.4 1.0 1 1/4 
POPSPIKE 100 35.0 11.7 3 15.6 1.0 1 0/4 
300 63.4 11.0 1 3 28.1 10.3 3 1/8 
500 50.2 5.3 4 2/6 
10 8.8 17.0 1 17.3 1.5 1 1 1/4 
50 34.6 1.0 1 16.8 14.0 2 1/4 
EPSP 100 4/4 
300 62.4 4.0 1 1 16.1 3.0 2 4/8 
500 21.7 2.0 1 1 21 .5 2.5 1 1 2/6 
10 4.0 2.0 1 3/4 
50 5.4 9.0 1 2 1/4 
LATENCY 100 8.0 3.7 1 2 1/4 
300 5.5 4.2 1 5 2/8 
500 5.3 9.7 3 3.0 12.0 2 1/6 
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Table 4: The effect of MET (10 ug, beta-antagonist), ISO (30 
ug, beta-agonist) alone and 30 rrdn. after MET, and NE (10 ug) 
alone and 30 rrdn. after MET on popspike amplitude following 
rev injection in the anaesthetized rat. MEAN represents an 
average of the maximal change within 3 0 rrdnutes post-injection 
that differs significantly from baseline. DELAY refers to an 
average of the time from injection until a significant effect. 
The number of significant effects of duration less than or 
greater than 20 rrdnutes is listed. 
INCREASE DECREASE NO CHANGE 
Drug Condition MEAN DELAY n<20 n>20 MEAN DELAY n<20 n>20 n/N 
(%) (min) min min (%) (min) min min 
MET 70.5 10.0 1 3 25.1 2.7 5 2 4/15 
ISO ALONE 45.8 12.0 4 0/4 
ISO AFTER MET 37.8 16.5 2 2/4 
NE ALONE 55.8 9.3 4 0/4 
NEAFTER MET 75.5 4.7 3 36.6 13.8 5 0/8 
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Table 5: The effect of PHENT (30 ug, alpha- antagonist), PE 
(50 ug, alpha-agonist) alone and 30 ~n. after PHENT, and NE 
(lO ug) alone and lS ~n. after PHENT on popspike amplitude 
following rev injection in the anaesthetized rat. MEAN 
represents an average of the maximal change within 3 0 ~nutes 
post-injection that differs significantly from baseline. DELAY 
refers to an average of the time from injection until a 
significant effect. The number of significant effects of 
duration less than or greater than 20 ~nutes is listed. 
INCREASE DECREASE NO CHANGE 
Drug Condition MEAN DELAY n<20 n>20 MEAN DELAY n<20 n>20 n/N 
(%) (min) min min (%) (min) min min 
PHENT 98.2 6.0 2 4/6 
PEALONE 56.9 3.5 2 19.4 1.0 1 1/4 
PE AFTER PHENT 45.2 1.0 1 61 .2 7.0 1 2/4 
NEALONE 55.8 9.3 4 0/4 
NE AFTER PHENT 37.8 10.0 1 63.8 1.0 2 1/4 
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Table 6: The effect of saline and NE (10 ug) on popspike 
amplitude following ICV injection in the awake, behaving 
(chronic) rat. The effect of NE (10 ug) on popspike amplitude 
in the anaesthetized (acute) rat is included for comparison. 
MEAN represents an average of the maximal change w1thin 30 
minutes post-injection that differs significantly from 
baseline. DELAY refers to an average of the time from 
injection until a significant effect. The number of 
significant effects of duration less than or greater than 20 
minutes is listed. 
INCREASE DECREASE NO CHANGE 
DRUG DOSE MEAN n<20 n>20 MEAN n<20 n>20 n/N 
(%) min min (%) min min 
SALINE CHRONIC 2 ul -32.7 1 1/2 
NE CHRONIC 10 ug 46.0 4 1 44.9 1* 0/6 
NEACUTE 10 ug 55.8 4 0/4 
* Followed by a significant increase at 90 and 180 min. 
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Table 7 : The percent time spent en~aging in various 
behaviours during ten minute intervals prlor to and following 
rev injections of NE (10 ug, n=S animals, 7 injections) and 
saline (n=2) in the awake rat . Electrophysiological 
stimulation and recording were also taking place. 
A) Norepinephrine (n=5). 
No Head/Paw Standing On 
Time Interval Movement Movement Grooming Walking Sleeping Hind Legs Chewing 
Before 61.4 6.1 29.4 2.8 0.0 0.2 0.0 
0 min After 26.7 10.2 2.1 53.4 0.0 4.9 2.6 
10 min After 76.0 9.3 0.0 13.6 0.2 1.0 0.0 
20 min After 64.1 8.3 4.0 5.5 18.1 0.0 0.0 
B) Saline (n=2). 
No Head/Paw Standing On 
Time Interval Movement Movement Grooming Walking Sleeping Hind Legs Chewing 
Before 70.8 8.4 12.5 5.8 0.0 2.5 0.0 
0 min After 44.0 6.7 34.3 13.4 0.0 1.7 0.0 
10 min After 90.8 5.9 0.9 1.7 0.9 0.0 0.0 
20 min After 55.9 6.7 3.4 12.5 21 .7 0.0 0.0 
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Figure 1: Mean popspike amplitude following NE 1 ug (n=4) 1 10 
ug (n=4) 1 50 ug (n=4) 1 and 100 ug (n=6) ICV injection in the 
anaesthetized rat at time zero. All results are plotted as a 
percentage of baseline. 
-?ft. 150 
......_ 
w 140 0 
~ 130 
~ 120 
~ 110 
~ 100 
a.. 
en 
a.. 
0 
a.. 
90 
80 
-10 
D 
8 
0 
76 
D 
•• 
•• 
.0 . . 
• • 0 
• •• o oo 
0 
oo 
10 
TIME (min) 
0 
0 0 
20 
I o 1 0 ug • 30 ug o 60 ug I 
oo 0 
0 0 
0 
0 
30 
Figure 2: Mean popspike amplitude following ISO 10 ug (n=4), 
30 ug (n=4), and 60 ug (n=4) ICV injection in the 
anaesthetized rat at time zero. All results are plotted as a 
percentage of baseline. 
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Figure 4: Examples of long-lasting potentiation of popspike 
amplitude following NE, ISO (beta-agonist), and PE (alpha-
agonist) ICV injection in the anaesthetized rat at time zero. 
All results are plotted as a percentage of baseline. 
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Figure 5 : Changes in popspike onset latency following ICV 
injection of NE, ISO (beta-agonist), and PE (alpha-agonist) in 
the anaesthetized rat at time zero. Results are combined for 
all doses that produced significant potentiation of the 
popspike amplitude. All results are plotted as a percentage of 
baseline. (See also Tables 1 - 3.) 
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Figure 6: Example of the effect of a single NE ICV injection 
on popspike amplitude, EPSP slope, and popspike onset latency. 
All results are plotted as a percentage of baseline. 
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Figure 7: Example of the effect of a single ISO (beta-agonist) 
ICV injection on popspike amplitude, EPSP slope, and popspike 
onset latency. All results are plotted as a percentage of 
baseline. 
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Figure 8: Example of the effect of a single PE (alpha-agonist) 
rev injection on popspike amplitude, EPSP slope, and popspike 
onset latency. All results are plotted as a percentage of 
baseline. 
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Figure 9: Comparison of the effect of ISO (beta-agonist) and 
NE, alone and following the injection of MET (beta-
antagonist), on popspike amplitude in the anaesthetized rat. 
Means of the maximal effect within 30 min. of the ICV 
injection are presented. Vertical lines represent one standard 
deviation. * represents significant difference (p < 0.05). 
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Figure 10: Comparison of the effect of PE (alpha-agonist) and 
NE, alone and following the injection of PHENT (alpha-
antagonist), on popspike amplitude in the anaesthetized rat. 
Means of the maximal effect within 30 min. of the ICV 
injection are presented. Vertical lines represent plus or 
minus one standard deviation. * represents significant 
difference (p < 0.05). 
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Figure 11: The effect of six individual NE (10 ug) ICV 
injections on popspike amplitude in the awake, behaving rat. 
Results were analyzed as ten minute means and plotted as a 
~ercentage of the ten minute baseline period (the first point 
ln each series) . 
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inJection on popspike amplitude and EPSP slope in the awake, 
behaving rat. Results were analyzed as ten mJnute means and 
plotted as a percentage of the ten mJnute baseline period (the 
first point ln each series) . 
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Figure 13: Comparison of the effect of saline and NE (10 ug) 
rev injection on popspike amplitude in anaesthetized and 
awake, behaving rats. Results were averaged as ten minute 
means and plotted as a percentage of the ten minute baseline 
period (the first point in each series) . 
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Figure 14: Comparison of the effect of saline and NE (10 ug) 
rev injection on EPSP slope in anaesthetized and awake, 
behaving rats. Results were averaged as ten minute means and 
plotted as a percentage of the ten minute baseline period (the 
first point in each series). Note: Y-axis is on same scale as 
Figure 13. 
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Figure 15: Example of the effect of NE (10 ug) ICV injection 
on popspike amplitude in an awake, behaving rat. The amplitude 
of individual popspikes is plotted separately for each 
category of behaviour. Injection was carried out at the end of 
the ten-minute baseline period (see arrow) . 
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Figure 16: The mean popspike amplitude associated with 
different behaviours observed in the first ten minutes of 
recording over successive days in an awake, behaving rat. 
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Figure 17: The mean popspike amplitude associated with 
different behaviours observed during recording over successive 
days in an awake, behaving rat. Note that the x-axis is 
discontinuous. The last four points re~resent the baseline 
period and three time periods followlng NE (10 ug) ICV 
injection on the same day. 
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